As a result of the significant disruption that is being caused by the COVID-19 pandemic we are very aware that many researchers will have difficulty in meeting the timelines associated with our peer review process during normal times. Please do let us know if you need additional time. Our systems will continue to remind you of the original timelines but we intend to be highly flexible at this time.
COVID-19 and impact on peer review
SARS-CoV-2 vaccine infection of human cell lines
Sarah Gilbert, David Matthews and colleagues present the first analysis of the ChAdOx1 nCoV-19 vaccine’s transcriptomic and proteomic repertoire in cell culture.
Special issue: Impact of genomics on precision public health
Our special issue on ‘The impact of genomics on precision public health’, guest edited by Muin Khoury and Kathryn Holt has launched.
Untreated breast cancer and initial metastatic event
Paul Cottu and colleagues conduct a multicentre prospective clinical trial on advanced breast cancer patients with profiling of the initial metastasis to derive prognostic and therapeutically relevant information.
Editing GWAS
Daniel Bauer and colleagues discuss the challenges in interrogating causal variants, points for consideration in experimental design and interpretation of GWAS locus mechanisms.
Reviews, Research Highlights and Commentaries
Read authoritative Reviews, Opinions and other content commissioned by the Genome Medicine Editors from leading researchers:
Commentaries (including Editorials, Comments, Opinions, Q&As and Meeting reports)
Articles
-
-
Emerging genetic complexity and rare genetic variants in neurodegenerative brain diseases
-
PRMT1-mediated H4R3me2a recruits SMARCA4 to promote colorectal cancer progression by enhancing EGFR signaling
-
In vivo genome editing in mouse restores dystrophin expression in Duchenne muscular dystrophy patient muscle fibers
-
Functional interpretation of ATAD3A variants in neuro-mitochondrial phenotypes
-
A practical guide to single-cell RNA-sequencing for biomedical research and clinical applications
-
Analysis of 100,000 human cancer genomes reveals the landscape of tumor mutational burden
-
Gut microbiome-host interactions in health and disease
-
Constructing narratives of heroism and villainy: case study of Myriad's BRACAnalysis® compared to Genentech's Herceptin®
-
Alterations in fecal microbiota composition by probiotic supplementation in healthy adults: a systematic review of randomized controlled trials
Focus: Fertility
Read the latest papers on fertility across BMC flagship journals.
Cisplatin and carboplatin result in similar gonadotoxicity in immature human testis with implications for fertility preservation in childhood cancer
Melissa D. Tharmalingam et al.
Published in BMC Medicine 04 December 2020
Large-scale discovery of male reproductive tract-specific genes through analysis of RNA-seq datasets
Matthew Robertson et al.
Published in BMC Biology 19 August 2020
DNA methylation and body mass index from birth to adolescence: meta-analyses of epigenome-wide association studies
Florianne Vehmeijer et al.
Published in Genome Medicine 25 November 2020
The Tug1 lncRNA locus is essential for male fertility
Jordan Lewandowski et al.
Published in Genome Biology 07 September 2020
Aims and scope
Genome Medicine publishes important advances of broad interest in the application of genetics, genomics and multi-omics to understand, diagnose and treat disease. The Journal aims to bridge the basic science and clinical research communities in areas that include, but are not limited to: cancer genomics, immuno-oncology, immunogenomics, infectious disease, microbiome, cardiology, neurogenomics, systems medicine, clinical genomics, gene therapies, precision medicine, and clinical trials. The Journal content includes original research, method, software, database and guideline articles as well as reviews, opinions and commentaries.
Article collections
Special issue
Translating the microbiome in health and disease
Guest editor: Ramnik Xavier
Special issue
Clinical interpretation of genome variation
Guest editors: Heidi Rehm and Douglas Fowler
Collection
A decade of Genome Medicine
Special issue
Tumor immune microenvironment and immunotherapy
Guest editors: Zlatko Trajanoski and Noel de Miranda
From the blog
- Editorial Board
- Editorial Team
- Sign up for article alerts and news from this journal
- Contact us
-
Announcements
C19 Rapid Review initiative
Genome Medicine has joined the C19 Rapid Review initiative, a cross-publisher collaboration to ensure that COVID-19 research is reviewed and published as quickly and openly as possible. Learn more here.
Submissions from medRxiv
Authors are now able to submit manuscripts to Genome Medicine directly from medRxiv without having to re-upload files.
Portable peer review
To reduce time spent on serial submissions and iterative reviewing, Genome Medicine offers to consider manuscripts on the basis of reviews received at other journals. We also support transfers of reviews obtained at Genome Medicine to other journals, including those outside of BMC and Springer Nature. Learn more from our peer review policy page.
COVID-19 submissions
In response to the current SARS-CoV-2 pandemic Genome Medicine editors will treat relevant submissions with high priority.
Follow
Annual Journal Metrics
-
Speed
74 days to first decision for reviewed manuscripts only
26 days to first decision for all manuscripts
167 days from submission to acceptance
21 days from acceptance to publicationCitation Impact
10.675 - 2-year Impact Factor
10.637 - 5-year Impact Factor
1.833 - Source Normalized Impact per Paper (SNIP)
5.084 - SCImago Journal Rank (SJR)Usage
1,200,539 Downloads
2,348 Altmetric Mentions
